• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Nat Commun . High-resolution epidemiological landscape from ~290,000 SARS-CoV-2 genomes from Denmark

tetano

Editor, Senior Moderator
Nat Commun


. 2024 Aug 20;15(1):7123.
doi: 10.1038/s41467-024-51371-0. High-resolution epidemiological landscape from ~290,000 SARS-CoV-2 genomes from Denmark

Mark P Khurana[SUP] #[/SUP][SUP] 1 [/SUP], Jacob Curran-Sebastian[SUP] #[/SUP][SUP] 2 [/SUP], Neil Scheidwasser[SUP] #[/SUP][SUP] 2 [/SUP], Christian Morgenstern[SUP] 3 [/SUP], Morten Rasmussen[SUP] 4 [/SUP], Jannik Fonager[SUP] 4 [/SUP], Marc Stegger[SUP] 5 6 [/SUP], Man-Hung Eric Tang[SUP] 5 [/SUP], Jonas L Juul[SUP] 7 [/SUP], Leandro Andrés Escobar-Herrera[SUP] 5 [/SUP], Frederik Trier Møller[SUP] 8 [/SUP]; Danish COVID-19 Genome Consortium (DCGC); Mads Albertsen[SUP] 9 [/SUP], Moritz U G Kraemer[SUP] 10 [/SUP], Louis du Plessis[SUP] 11 [/SUP], Pikka Jokelainen[SUP] 8 [/SUP], Sune Lehmann[SUP] 7 [/SUP], Tyra G Krause[SUP] 12 [/SUP], Henrik Ullum[SUP] 13 [/SUP], David A Duchêne[SUP] 2 [/SUP], Laust H Mortensen[SUP] 2 14 [/SUP], Samir Bhatt[SUP] 2 3 [/SUP]



Collaborators, Affiliations
Abstract

Vast amounts of pathogen genomic, demographic and spatial data are transforming our understanding of SARS-CoV-2 emergence and spread. We examined the drivers of molecular evolution and spread of 291,791 SARS-CoV-2 genomes from Denmark in 2021. With a sequencing rate consistently exceeding 60%, and up to 80% of PCR-positive samples between March and November, the viral genome set is broadly whole-epidemic representative. We identify a consistent rise in viral diversity over time, with notable spikes upon the importation of novel variants (e.g., Delta and Omicron). By linking genomic data with rich individual-level demographic data from national registers, we find that individuals aged < 15 and > 75 years had a lower contribution to molecular change (i.e., branch lengths) compared to other age groups, but similar molecular evolutionary rates, suggesting a lower likelihood of introducing novel variants. Similarly, we find greater molecular change among vaccinated individuals, suggestive of immune evasion. We also observe evidence of transmission in rural areas to follow predictable diffusion processes. Conversely, urban areas are expectedly more complex due to their high mobility, emphasising the role of population structure in driving virus spread. Our analyses highlight the added value of integrating genomic data with detailed demographic and spatial information, particularly in the absence of structured infection surveys.


 
Back
Top Bottom